Impentri
Development of Impentri, an intravenous imatinib formulation for COVID-19 acute respiratory distress syndrome (ARDS)
keywords: IMI projects Respiratory diseases Infectious diseases Coronaviruses Conducting clinical trials
- Project website
- https://impentri.exvastat.com/
- Start date
- 2020-07-01
- End date
- 2022-06-30
- Funding
- IMI2 - Call 21 (Grant number 101005142)
- Types
- IMI projects
